ADVB

Advanced Biomed Inc.
CAPPED RATING

Advanced Biomed Inc. (ADVB) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (C+); its weakest is Momentum (D).

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
C+
Factor Score 2.8 / 5.0
Growth
C+
Factor Score 2.5 / 5.0
Profitability
D
Factor Score 1.5 / 5.0
Momentum
D
Factor Score 1.3 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA -1.0
Rev Growth YoY N/A
Gross Margin N/M
Price Return 3M -74.5%
Price Return 12M -75.2%
Catalyst Signal 0.00
Market Cap $3.7M
TTM Revenue $127.6K
Price / Sales 28.7
ROE -79.5%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C+ (2.8) C+ (2.5) D (1.5) D (1.3) C+ (2.6) C- (2.1)
2026-11-10 C+ (2.8) C+ (2.5) D (1.5) D+ (1.7) C+ (2.6) C (2.2)
2026-11-03 B- (2.9) C+ (2.5) D (1.4) D+ (1.7) C+ (2.7) C (2.2)
2026-10-27 C+ (2.8) C+ (2.5) D (1.4) D+ (1.8) C+ (2.6) C (2.2)
2026-10-20 C+ (2.7) C+ (2.5) D (1.4) C (2.3) C+ (2.6) C (2.3)
Page 1 of 4